Metal Abstraction Peptide With Superoxide Dismutase Activity
AssigneesEchogen, Inc., University of Kansas
InventorsJennifer Ann Stowell Laurence, Mary Elizabeth Krause, Timothy A. Jackson, Amanda Michelle Glass, George Laurence
Life of this patent
Estimating the term…
Abstract
Compositions comprising peptides that are capable of binding a metal are disclosed. Such compositions can be used for binding metal in a variety of contexts and environments. In various embodiments, peptides are used for antioxidant activity, anti-inflammatory activity, anti-pain therapy, as chemical reagents, and/or as superoxide dismutase mimics.
Claims104
A method of treating a defect in superoxide dismutase in a subject in need thereof, the method comprising administering to the subject a therapeutically-effective amount of:
- i) a peptide comprising a sequence XC1C2, wherein X is any natural or non-natural amino acid or amino acid analog, and further wherein C1 and C2 are each individually chosen from a cysteine and a sulfur-containing alpha or beta amino acid;
- and
- ii) a metal bound to the peptide.
A method of reducing pain in a subject in need thereof, the method comprising administering to the subject a therapeutically-effective amount of:
- i) a peptide comprising a sequence XC1C2, wherein X is any natural or non-natural amino acid or amino acid analog, and further wherein C1 and C2 are each individually chosen from a cysteine and a sulfur-containing alpha or beta amino acid;
- and
- ii) a metal bound to the peptide.
A method of reducing inflammation in a subject in need thereof, the method comprising administering to the subject a therapeutically-effective amount of:
- i) a peptide comprising a sequence XC1C2, wherein X is any natural or non-natural amino acid or amino acid analog, and further wherein C1 and C2 are each individually chosen from a cysteine and a sulfur-containing alpha or beta amino acid;
- and
- ii) a metal bound to the peptide.
A method of increasing in vivo half-life of a therapeutic polypeptide, the method comprising:
- i) providing a therapeutic polypeptide with an amino terminus, wherein the amino terminus has a sequence XC1C2, wherein X is any natural or non-natural amino acid or amino acid analog, and further wherein C1 and C2 are each individually chosen from a cysteine and a sulfur-containing alpha or beta amino acid;
- ii) forming a complex between a metal and the therapeutic polypeptide under conditions suitable for chiral inversion of C2;
- and
- iii) separating the metal from the therapeutic polypeptide with chirally inverted C2, wherein the in vivo half-life of the therapeutic polypeptide is increased.
A method of performing a chemical reaction, the method comprising contacting:
- i) a peptide comprising a sequence XC1C2, wherein X is any natural or non-natural amino acid or amino acid analog, wherein C1 and C2 are each individually chosen from a cysteine and a sulfur-containing alpha or beta amino acid, and wherein a metal is bound to the peptide;
- and
- ii) chemical starting materials,
- whereupon the chemical starting materials are combined into a product.
Dependencies are inferred from the claim text.